1. Medtech Insight
  2. >>Business
  3. >>R&D
  4. >>Clinical Trials

Edwards Stays On Track For ‘Mid-Teens’ TAVR Growth In 2021

 
• By Reed Miller

Edwards Lifesciences reported $1.2bn in sales in the first quarter of 2021, up 5% year-over-year and exceeding the projections the company offered three months ago.

Earning Report Q1

Edwards Lifesciences did not expect to show much revenue growth in the first quarter 2021, but its total sales grew 5% year-over-year during the quarter, including 4% growth for its flagship Sapien transcatheter aortic valve replacement (TAVR) business.

“Our sales were dramatically impacted in the last few weeks of Q1 2020 as procedures fell due to COVID-19 disruptions. One year later, after an extraordinarily difficult global crisis, I’m...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 
• By Natasha Barrow

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.